Incident diabetes risk is not increased in transgender individuals using hormone therapy

CONCLUSION: Despite studies reporting an increase in insulin resistance in feminizing hormone therapy and a decrease in insulin resistance in masculinizing hormone therapy, the incidence of diabetes in transgender individuals after initiation of hormone therapy was not different compared to the general population.PMID:34971391 | DOI:10.1210/clinem/dgab934

Source: The Journal of Clinical Endocrinology and Metabolism - December 31, 2021 Category: Endocrinology Authors: Daan van Velzen Chantal Wiepjes Nienke Nota Daniel van Raalte Ren ée de Mutsert Suat Simsek Martin den Heijer Source Type: research